REFERENCES
1. Colon Cancer Laparoscopic or Open Resection Study Group, Buunen M, Veldkamp R, Hop WC, Kuhry E, et al. Survival after laparoscopic surgery versus open surgery for colon cancer: long-term outcome of a randomised clinical trial. Lancet Oncol 2009;10:44-52.
2. Salem JF, Gummadi S, Marks JH. Minimally invasive approaches to colon cancer. Surg Oncol Clin N Am 2018;27:303-18.
3. Deijen CL, Vasmel JE, de Lange-de Klerk ESM, Cuesta MA, Coene PLO, et al. Ten-year outcomes of a randomised trial of laparoscopic versus open surgery for colon cancer. Surg Endosc 2017;31:2607-15.
4. Jayne DG, Guillou PJ, Thorpe H, Quirke P, Copeland J, et al. Randomized trial of laparoscopic-assisted resection of colorectal carcinoma: 3-year results of the UK MRC CLASICC trial group. J Clin Oncol 2007;25:3061-8.
5. Guerrieri M, Campagnacci R, De Sanctis A, Lezoche G, Massucco P, et al. Laparoscopic versus open colectomy for TNM stage III colon cancer: results of a prospective multicenter study in Italy. Surg Today 2012;42:1071-7.
6. Kitano S, Inomata M, Mizusawa J, Katayama H, Watanabe M, et al. Survival outcomes following laparoscopic versus open D3 dissection for stage II or III colon cancer (JCOG0404): a phase 3, randomised controlled trial. Lancet Gastroenterol Hepatol 2017;2:261-8.
7. Camilleri-Brennan J, Steele RJ. Quality of life after treatment for rectal cancer. Br J Surg 1998;85:1036-43.
8. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-92.
9. Mosconi P, Apolone G, Barni S, Secondino S, Sbanotto A, et al. Quality of life in breast and colon cancer long-term survivors: an assessment with the EORTC QLQ-C30 and SF-36 questionnaires. Tumori 2002;88:110-6.
10. Gujral S, Conroy T, Fleissner C, Sezer O, King PM, et al. Assessing quality of life in patients with colorectal cancer: an update of the EORTC quality of life questionnaire. Eur J Cancer 2007;43:1564-73.
11. Uwer L, Rotonda C, Guillemin F, Miny J, Kaminsky MC, et al. Responsiveness of EORTC QLQ-C30, QLQ-CR38 and FACT-C quality of life questionnaires in patients with colorectal cancer. Health Qual Life Outcomes 2011;9:70.
12. Sprangers MA, te Velde A, Aaronson NK. The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer 1999;35:238-47.
13. Batista-Miranda JE, Regalado Pareja R, Huguet Pérez J, Montlleo Sánchez M, Araño Bertran P. The use of the IPSS questionnaire in surgical patients. International Prostatic Symptom Score. Actas Urol Esp 1995;19:227-33. (in Spanish)
14. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, et al. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology 1997;49:822-30.
15. de Silva G, Furukan R, Goonewardene M. Validation of the Sinhala translation of the international consultation on incontinence modular questionnaire for female lower urinary tract symptoms among women in Sri Lanka. Int Urogynecol J 2017;28:1895-9.
16. Pourmomeny AA, Ghanei B, Alizadeh FA. Reliability and validity of the persian language version of the international consultation on incontinence questionnaire - male lower urinary tract symptoms (ICIQ-MLUTS). Low Urin Tract Symptoms 2018;10:190-2.
18. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000;26:191-208.
19. Moghadamyeghaneh Z, Carmichael JC, Mills S, Pigazzi A, Nguyen NT, et al. Variations in laparoscopic colectomy utilization in the United States. Dis Colon Rectum 2015;58:950-6.
20. Breukink SO, van der Zaag-Loonen HJ, Bouma EM, Pierie JP, Hoff C, et al. Prospective evaluation of quality of life and sexual functioning after laparoscopic total mesorectal excision. Dis Colon Rectum 2007;50:147-55.
21. Braga M, Frasson M, Vignali A, Zuliani W, Capretti G, et al. Laparoscopic resection in rectal cancer patients: outcome and cost-benefit analysis. Dis Colon Rectum 2007;50:464-71.
22. George D, Pramil K, Kamalesh NP, Ponnambatheyil S, Kurumboor P. Sexual and urinary dysfunction following laparoscopic total mesorectal excision in male patients: a prospective study. J Minim Access Surg 2018;14:111-7.
23. Guillou PJ, Quirke P, Thorpe H, Walker J, Jayne DG, et al. Short-term endpoints of conventional versus laparoscopic-assisted surgery in patients with colorectal cancer (MRC CLASICC trial): multicentre, randomised controlled trial. Lancet 2005;365:1718-26.
24. Jeong SY, Park JW, Nam BH, Kim S, Kang SB, et al. Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial. Lancet Oncol 2014;15:767-74.
25. Bonjer HJ, Deijen CL, Abis GA, Cuesta MA, van der Pas MH, et al. A randomized trial of laparoscopic versus open surgery for rectal cancer. N Engl J Med 2015;372:1324-32.
26. Andersson J, Abis G, Gellerstedt M, Angenete E, Angerås U, et al. Patient-reported genitourinary dysfunction after laparoscopic and open rectal cancer surgery in a randomized trial (COLOR II). Br J Surg 2014;101:1272-9.
27. Fleshman J, Branda M, Sargent DJ, Boller AM, George V, et al. Effect of laparoscopic-assisted resection vs open resection of stage II or III rectal cancer on pathologic outcomes: the ACOSOG Z6051 randomized clinical trial. JAMA 2015;314:1346-55.
28. Stevenson AR, Solomon MJ, Lumley JW, Hewett P, Clouston AD, et al. Effect of laparoscopic-assisted resection vs open resection on pathological outcomes in rectal cancer: the ALaCaRT randomized clinical trial. JAMA 2015;314:1356-63.
29. D'Annibale A, Pernazza G, Monsellato I, Pende V, Lucandri G, et al. Total mesorectal excision: a comparison of oncological and functional outcomes between robotic and laparoscopic surgery for rectal cancer. Surg Endosc 2013;27:1887-95.
30. Kim JY, Kim NK, Lee KY, Hur H, Min BS, et al. A comparative study of voiding and sexual function after total mesorectal excision with autonomic nerve preservation for rectal cancer: laparoscopic versus robotic surgery. Ann Surg Oncol 2012;19:2485-93.
31. Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP. Short-term clinical outcome of robot-assisted intersphincteric resection for low rectal cancer: a retrospective comparison with conventional laparoscopy. Surg Endosc 2013;27:48-55.
32. Park SY, Choi GS, Park JS, Kim HJ, Ryuk JP, et al. Urinary and erectile function in men after total mesorectal excision by laparoscopic or robot-assisted methods for the treatment of rectal cancer: a case-matched comparison. World J Surg 2014;38:1834-42.
33. Broholm M, Pommergaard HC, Gögenür I. Possible benefits of robot-assisted rectal cancer surgery regarding urological and sexual dysfunction: a systematic review and meta-analysis. Colorectal Dis 2015;17:375-81.
34. Kamali D, Omar K, Imam SZ, Jha A, Reddy A, et al. Patient quality of life and short-term surgical outcomes between robotic and laparoscopic anterior resection for adenocarcinoma of the rectum. Tech Coloproctol 2017;21:355-61.
35. Kim HJ, Choi GS, Park JS, Park SY, Yang CS, et al. The impact of robotic surgery on quality of life, urinary and sexual function following total mesorectal excision for rectal cancer: a propensity score-matched analysis with laparoscopic surgery. Colorectal Dis 2018;20:O103-13.
36. Kim JC, Lim SB, Yoon YS, Park IJ, Kim CW, et al. Completely abdominal intersphincteric resection for lower rectal cancer: feasibility and comparison of robot-assisted and open surgery. Surg Endosc 2014;28:2734-44.
37. Jayne D, Pigazzi A, Marshall H, Croft J, Corrigan N, et al. Effect of robotic-assisted vs conventional laparoscopic surgery on risk of conversion to open laparotomy among patients undergoing resection for rectal cancer: the ROLARR randomized clinical trial. JAMA 2017;318:1569-80.
38. Clancy C, Burke JP, Albert MR, O'Connell PR, Winter DC. Transanal endoscopic microsurgery versus standard transanal excision for the removal of rectal neoplasms: a systematic review and meta-analysis. Dis Colon Rectum 2015;58:254-61.
39. Allaix ME, Rebecchi F, Giaccone C, Mistrangelo M, Morino M. Long-term functional results and quality of life after transanal endoscopic microsurgery. Br J Surg 2011;98:1635-43.
40. Jakubauskas M, Jotautas V, Poskus E, Mikalauskas S, Valeikaite-Tauginiene G, et al. Fecal incontinence after transanal endoscopic microsurgery. Int J Colorectal Dis 2018;33:467-72.
41. Hompes R, Ashraf SQ, Gosselink MP, van Dongen KW, Mortensen NJ, et al. Evaluation of quality of life and function at 1 year after transanal endoscopic microsurgery. Colorectal Dis 2015;17:O54-61.
42. D'Ambrosio G, Paganini AM, Balla A, Quaresima S, Ursi P, et al. Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision. Surg Endosc 2016;30:504-11.
43. Verseveld M, Barendse RM, Gosselink MP, Verhoef C, de Graaf EJ, et al. Transanal minimally invasive surgery: impact on quality of life and functional outcome. Surg Endosc 2016;30:1184-7.
44. García-Flórez LJ, Otero-Díez JL, Encinas-Muñiz AI, Sánchez-Domínguez L. Indications and outcomes from 32 consecutive patients for the treatment of rectal lesions by transanal minimally invasive surgery. Surg Innov 2017;24:336-42.
45. Clermonts SHEM, van Loon YT, Wasowicz DK, Langenhoff BS, Zimmerman DDE. Comparative quality of life in patients following transanal minimally invasive surgery and healthy control subjects. J Gastrointest Surg 2018;22:1089-97.
46. Sylla P, Rattner DW, Delgado S, Lacy AM. NOTES transanal rectal cancer resection using transanal endoscopic microsurgery and laparoscopic assistance. Surg Endosc 2010;24:1205-10.
47. Lee GC, Sylla P. Shifting paradigms in minimally invasive surgery: applications of transanal natural orifice transluminal endoscopic surgery in colorectal surgery. Clin Colon Rectal Surg 2015;28:181-93.
48. Rasulov AO, Mamedli ZZ, Gordeyev SS, Kozlov NA, Dzhumabaev HE. Short-term outcomes after transanal and laparoscopic total mesorectal excision for rectal cancer. Tech Coloproctol 2016;20:227-34.
49. Chang TC, Kiu KT. Kiu. Transanal total mesorectal excision in lower rectal cancer: comparison of short-term outcomes with conventional laparoscopic total mesorectal excision. J Laparoendosc Adv Surg Tech A 2018;28:365-9.
50. Atallah SB, DuBose AC, Burke JP, Nassif G, deBeche-Adams T, et al. Uptake of transanal total mesorectal excision in North America: initial assessment of a structured training program and the experience of delegate surgeons. Dis Colon Rectum 2017;60:1023-31.
51. Maykel JA. Comprehensive training and safe implementation of a transanal total mesorectal excision program. Dis Colon Rectum 2017;60:995-6.
52. Maykel JA, Phatak UR, Suwanabol PA, Schlussel AT, Davids JS, et al. Initiation of a transanal total mesorectal excision program at an academic training program: evaluating patient safety and quality outcomes. Dis Colon Rectum 2017;60:1267-72.
53. Koedam TW, van Ramshorst GH, Deijen CL, Elfrink AK, Meijerink WJ, et al. Transanal total mesorectal excision (TaTME) for rectal cancer: effects on patient-reported quality of life and functional outcome. Tech Coloproctol 2017;21:25-33.
54. Veltcamp Helbach M, Koedam TWA, Knol JJ, Velthuis S, Bonjer HJ, et al. Quality of life after rectal cancer surgery: differences between laparoscopic and transanal total mesorectal excision. Surg Endosc ; doi: 10.1007/s00464-018-6276-z.
55. Deijen CL, Velthuis S, Tsai A, Mavroveli S, de Lange-de Klerk ES, et al. COLOR III: a multicentre randomised clinical trial comparing transanal TME versus laparoscopic TME for mid and low rectal cancer. Surg Endosc 2016;30:3210-5.
56. Serra-Aracil X, Zárate A, Mora L, Serra-Pla S, Pallisera A, et al. Study protocol for a multicenter prospective controlled and randomized trial of transanal total mesorectal excision versus laparoscopic low anterior resection in rectal cancer. Int J Colorectal Dis 2018;33:649-55.
57. Damle A, Damle RN, Flahive JM, Schlussel AT, Davids JS, et al. Diffusion of technology: trends in robotic-assisted colorectal surgery. Am J Surg 2017;214:820-4.
58. Smith JJ, Chow OS, Gollub MJ, Nash GM, Temple LK, et al. Organ preservation in rectal adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management. BMC Cancer 2015;15:767.
59. Habr-Gama A, Lynn PB, Jorge JM, São Julião GP, Proscurshim I, et al. Impact of organ-preserving strategies on anorectal function in patients with distal rectal cancer following neoadjuvant chemoradiation. Dis Colon Rectum 2016;59:264-9.
